Indaptus Therapeutics, Inc.

Historical 13F Holders

Symbol
INDP
CUSIP
45339J105
All holders as of
Q1 2025
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 45339J105 since 12/18/2024, largest first.

Filer % of Class Filed
Lazar David E. 13D/A 47.9% 3/24/2026
Event 3/23/2026
Yao Yun 13D/A 27.3% 10/22/2026
Event 10/16/2026
SINO LION VENTURES Ltd 13D/A
25.3% 10/22/2026
Event 10/16/2026
Meckler Jeffrey A 13D/A 12.7% 12/30/2025
Event 12/22/2025
Dai Junyi 13D/A 7.3% 10/22/2026
Event 10/16/2026
Yang Ting 13D/A 6.5% 10/21/2026
Event 10/16/2026
Newman Michael James 13D/A 5.4% 12/30/2025
Event 12/22/2025
Under 5%, checked the "5 percent or less" box, or amended by a later filing (1)
YA II PN, Ltd. 13G/A
0% 4/6/2026
Event 12/31/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2025 Q1 20 687 k $378k
2024 Q4 21 638 k $540k
2024 Q3 19 605 k $750k
2024 Q2 22 601 k $1.26M
2024 Q1 18 590 k $1.32M
2023 Q4 20 603 k $1.06M
2023 Q3 17 571 k $1.57M
2023 Q2 16 584 k $1.11M
2023 Q1 16 579 k $1.08M
2022 Q4 19 596 k $867k
2022 Q3 19 567 k $1.22M
2022 Q2 18 501 k $1.31M
2022 Q1 18 1.71 M $6.81M
2021 Q4 16 1.84 M $10.5M
2021 Q3 16 542 k $4.24M